Principal Financial Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-223,935
| Closed | -$2.1M | – | 2490 |
|
|
2020
Q3 | $2.1M | Sell |
223,935
-39,289
| -15% | -$373K | ﹤0.01% | 1727 |
|
|
2020
Q2 | $2.01M | Buy |
263,224
+962
| +0.4% | +$7.36K | ﹤0.01% | 1698 |
|
|
2020
Q1 | $1.62M | Sell |
262,262
-10,643
| -4% | -$93.8K | ﹤0.01% | 1646 |
|
|
2019
Q4 | $3.32M | Buy |
272,905
+366
| +0.1% | +$4K | ﹤0.01% | 1635 |
|
|
2019
Q3 | $3.15M | Sell |
272,539
-3,596
| -1% | -$37.8K | ﹤0.01% | 1643 |
|
|
2019
Q2 | $2.76M | Sell |
276,135
-7,916
| -3% | -$85.4K | ﹤0.01% | 1672 |
|
|
2019
Q1 | $3.66M | Sell |
284,051
-1,281
| -0.4% | -$19.1K | ﹤0.01% | 1634 |
|
|
2018
Q4 | $4.33M | Buy |
285,332
+1,613
| +0.6% | +$30.7K | ﹤0.01% | 1552 |
|
|
2018
Q3 | $5.67M | Buy |
283,719
+11,096
| +4% | +$253K | 0.01% | 1561 |
|
|
2018
Q2 | $5.32M | Buy |
272,623
+4,992
| +2% | +$110K | ﹤0.01% | 1578 |
|
|
2018
Q1 | $5.39M | Sell |
267,631
-2,831
| -1% | -$47.9K | 0.01% | 1533 |
|
|
2017
Q4 | $3.58M | Buy |
270,462
+3,338
| +1% | +$50.3K | ﹤0.01% | 1656 |
|
|
2017
Q3 | $4.93M | Sell |
267,124
-437
| -0.2% | -$8.14K | ﹤0.01% | 1561 |
|
|
2017
Q2 | $4.92M | Buy |
267,561
+5,632
| +2% | +$112K | ﹤0.01% | 1555 |
|
|
2017
Q1 | $5.91M | Buy |
261,929
+4,008
| +2% | +$96K | 0.01% | 1475 |
|
|
2016
Q4 | $8.98M | Buy |
257,921
+9,722
| +4% | +$290K | 0.01% | 1243 |
|
|
2016
Q3 | $6.08M | Sell |
248,199
-28,724
| -10% | -$718K | 0.01% | 1392 |
|
|
2016
Q2 | $6.62M | Buy |
276,923
+4,773
| +2% | +$109K | 0.01% | 1298 |
|
|
2016
Q1 | $6.37M | Buy |
272,150
+237,868
| +694% | +$5.65M | 0.01% | 1261 |
|
|
2015
Q4 | $1.03M | Buy |
34,282
+14,017
| +69% | +$453K | ﹤0.01% | 1755 |
|
|
2015
Q3 | $805K | Buy |
20,265
+15,001
| +285% | +$931K | ﹤0.01% | 1804 |
|
|
2015
Q2 | $364K | Sell |
5,264
-1,115
| -17% | -$70.1K | ﹤0.01% | 1914 |
|
|
2015
Q1 | $348K | Buy |
6,379
+342
| +6% | +$16.3K | ﹤0.01% | 1890 |
|
|
2014
Q4 | $257K | Buy |
+6,037
| New | +$218K | ﹤0.01% | 1971 |
|
|
2014
Q2 | – | Sell |
-10,429
| Closed | -$202K | – | 2336 |
|
|
2014
Q1 | $202K | Sell |
10,429
-99
| -0.9% | -$2.1K | ﹤0.01% | 2131 |
|
|
2013
Q4 | $256K | Hold |
10,528
| – | – | ﹤0.01% | 2062 |
|
|
2013
Q3 | $226K | Sell |
10,528
-690
| -6% | -$16.3K | ﹤0.01% | 2067 |
|
|
2013
Q2 | $250K | Buy |
+11,218
| New | +$247K | ﹤0.01% | 2002 |
|
Principal Financial Group's AMAG Position: Q4 2020 in Review
Principal Financial Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 223,935 shares — an estimated $2.1M sold.
Principal Financial Group first reported a position in AMAG in Q2 2013 and held it in 28 quarters. The position peaked at $8.98M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Principal Financial Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Principal Financial Group sold 223,935 AMAG Pharmaceuticals shares in Q4 2020, an estimated $2.1M.
- Principal Financial Group first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 28 quarters.
- Principal Financial Group's AMAG Pharmaceuticals position peaked at $8.98M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Principal Financial Group's 13F filing for Q4 2020, filed 8 Feb 2021.